2,061
Views
13
CrossRef citations to date
0
Altmetric
Brief Report

PD-L2 amplification and durable disease stabilization in patient with urothelial carcinoma receiving pembrolizumab

, , , , , , , , , , , , & show all
Article: e1460298 | Received 17 Mar 2018, Accepted 27 Mar 2018, Published online: 29 May 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (13)